# Ischemic Stroke: Neurosurgical Considerations

## Overview

While ischemic stroke management is primarily medical and endovascular, neurosurgeons play a critical role in managing life-threatening complications. Decompressive hemicraniectomy (DHC) for malignant MCA infarction is one of the most evidence-supported surgical interventions in neurosurgery. Posterior fossa stroke with obstructive hydrocephalus requires urgent neurosurgical intervention. Understanding the landmark trials (DECIMAL, DESTINY, HAMLET) and the indications for surgical decompression is essential for the neurosurgery resident.

## Malignant MCA Infarction

### Pathophysiology

Complete MCA territory infarction leads to massive cytotoxic edema peaking at 48-96 hours. Brain swelling causes transtentorial herniation with uncal compression of CN III, brainstem compression, and contralateral ACA territory ischemia. Mortality with medical management alone reaches 70-80%. This affects 1-10% of all ischemic stroke patients.

### Clinical Presentation

Patients present with dense hemiplegia, hemianesthesia, and hemianopia, with gaze deviation toward the lesion. Aphasia occurs with dominant hemisphere involvement and neglect with non-dominant hemisphere strokes. Progressive decrease in consciousness develops over 24-96 hours as edema worsens. Signs of herniation include ipsilateral pupil dilation, contralateral motor posturing, and the Cushing response.

### Predictors of Malignant Course

Predictors include infarct volume exceeding 50% of MCA territory on early CT, DWI volume greater than 82 mL within 6 hours (the strongest predictor), NIHSS above 20 for dominant hemisphere or above 15 for non-dominant hemisphere, dense MCA sign or ICA occlusion on CTA, decreased consciousness within the first 24 hours, and additional ACA or PCA territory involvement.

## Decompressive Hemicraniectomy (DHC)

### Landmark Trials

DECIMAL (2007) was a French RCT of 38 patients aged 18-55, with DHC within 24 hours versus medical management. DHC reduced mortality from 78% to 25%. DESTINY I (2007) was a German RCT of 32 patients aged 18-60, with DHC within 36 hours, reducing mortality from 53% to 12%. HAMLET (2009) was a Dutch RCT of 64 patients aged 18-60, showing that DHC within 48 hours reduced mortality, but surgery after 48 hours showed diminished benefit.

| Trial | Year | N | Age | Timing | Mortality (Surgery vs Medical) | Key Finding |
|-------|------|---|-----|--------|-------------------------------|-------------|
| DECIMAL | 2007 | 38 | 18-55 | <24 h | 25% vs 78% | DHC reduces mortality |
| DESTINY I | 2007 | 32 | 18-60 | <36 h | 12% vs 53% | DHC reduces mortality |
| HAMLET | 2009 | 64 | 18-60 | <48 h | Reduced | Benefit diminishes after 48 h |
| Pooled analysis | 2007 | 93 | 18-60 | <48 h | 22% vs 71% (NNT=2) | mRS 0-3: 43% vs 21% |
| DESTINY II | 2014 | 112 | >60 | <48 h | 33% vs 70% | Survival with severe disability (mRS 4-5) |

The pooled analysis (Vahedi et al., 2007) combined data from all three trials (93 patients). DHC reduced mortality dramatically (22% versus 71%, NNT of 2) and improved favorable outcome defined as mRS 0-3 (43% versus 21%, NNT of 4). However, a significant proportion survived with moderate disability (mRS 4), raising quality-of-life concerns.

DESTINY II (2014) studied patients over 60 years (up to age 82) with DHC within 48 hours. DHC reduced mortality (33% versus 70%), but increased the proportion surviving with severe disability (mRS 4-5: 32% versus 28%), and no patient achieved mRS 0-2. This raises ethical questions about DHC benefit in elderly patients.

In summary, DHC for malignant MCA infarction in patients 60 or younger has strong (Class I) evidence for survival benefit when performed within 48 hours. For patients over 60, survival benefit exists but the quality of survival is debated, making shared decision-making with family essential. After 48 hours, benefit is diminished and surgery should ideally be performed early.

### Surgical Technique

The bone flap must be at least 12 cm in diameter (15 cm preferred), including frontal, parietal, and temporal bone; smaller flaps are inadequate. The temporal bone must be taken flush with the middle fossa floor to prevent temporal lobe herniation beneath the bone edge. Generous duraplasty with a dural substitute (bovine pericardium, Gore-Tex, or autologous pericranium) is essential; durotomy alone without duraplasty provides insufficient decompression. Infarcted brain is not resected (unlike traumatic decompressive craniectomy where non-viable tissue may be debrided). The dura should not be closed tightly, as the goal is to allow swollen brain to expand externally. A subgaleal drain prevents epidural hematoma formation.

### Postoperative Management

The head of bed is elevated. Compression of the decompressed side is avoided by positioning the patient supine or on the contralateral side. ICP monitoring is usually not needed after adequate decompression. Osmotherapy may still be used for residual edema. Cranioplasty is typically performed 6-12 weeks after DHC, with earlier cranioplasty (within 3-6 weeks) potentially improving neurological recovery through resolution of the syndrome of the trephined.

<image>
Preoperative and postoperative CT comparison of decompressive hemicraniectomy for malignant MCA infarction. The preoperative CT shows a large right MCA territory infarct with severe midline shift, effaced basal cisterns, and uncal herniation. The postoperative CT shows the bone flap removed with brain expanding through the craniectomy defect, reduced midline shift, and reopened basal cisterns. The surgical technique diagram shows the minimum bone flap dimensions (>=12 cm), temporal floor flush cut, and augmentative duraplasty with the brain expanding outward. Radiological and surgical teaching illustration.
</image>

## Posterior Fossa Stroke

### Pathophysiology

Cerebellar infarction (in PICA, AICA, or SCA territory) can cause massive posterior fossa edema. The edema compresses the fourth ventricle, causing obstructive hydrocephalus, and direct brainstem compression can be rapidly fatal. Posterior fossa stroke accounts for approximately 2% of all ischemic strokes but carries high mortality without intervention.

### Clinical Presentation

Patients present with vertigo, nausea, vomiting, and ipsilateral limb and truncal ataxia, along with dysarthria and dysphagia. Progressive drowsiness develops from hydrocephalus or brainstem compression. Rapid deterioration can occur within hours, making close neurological monitoring essential.

### Neurosurgical Management

EVD placement is indicated for acute obstructive hydrocephalus with declining consciousness. However, EVD alone may be insufficient if mass effect from the infarcted cerebellum causes direct brainstem compression, and there is risk of upward transtentorial herniation with aggressive supratentorial CSF drainage. Suboccipital decompressive craniectomy is indicated for large cerebellar infarction with brainstem compression despite EVD. Infarcted, swollen cerebellar tissue is removed if non-viable, C1 laminectomy may be needed for adequate decompression, and duraplasty provides adequate posterior fossa decompression. Early intervention before brainstem signs develop is associated with better outcomes; waiting for full brainstem compression before surgery should be avoided.

### Evidence

No RCTs exist for posterior fossa decompressive surgery (and are unlikely to be performed given clear clinical benefit). Observational data consistently shows reduced mortality (20-30% versus 80% with conservative management for severe cases). Patients can make excellent functional recoveries even after large cerebellar infarctions.

## Other Neurosurgical Considerations in Ischemic Stroke

### Hemorrhagic Transformation

Hemorrhagic transformation occurs in 5-40% of ischemic strokes, particularly after reperfusion therapy. Petechial types (HI1/HI2) are usually asymptomatic, while parenchymal hematoma types (PH1/PH2) cause mass effect. PH2 (hematoma greater than 30% of infarct area with mass effect) is clinically significant and may require surgical evacuation if large. Management involves reversing anticoagulation and considering craniotomy for large hematomas with herniation.

### Cerebral Edema Management

Osmotherapy with mannitol (0.5-1.5 g/kg IV bolus) or hypertonic saline (23.4%, 30 mL bolus) serves as a temporizing measure while preparing for DHC. Hyperventilation (target pCO2 30-35 mmHg) is short-term only due to rebound effects. Hypothermia has been investigated but is not standard of care due to rebound edema during rewarming. Corticosteroids are not effective for cytotoxic edema in ischemic stroke, unlike vasogenic edema in tumors.

### The Neurosurgeon on the Stroke Team

The neurosurgeon provides rapid availability for DHC consultation (especially after hours), EVD placement for hydrocephalus, ICP monitoring when needed, hemorrhagic complication management, and participation in multidisciplinary stroke conferences.

<image>
Sagittal and axial CT/MRI showing a large PICA territory cerebellar infarction with fourth ventricle compression and obstructive hydrocephalus. A comparison panel shows the post-decompressive suboccipital craniectomy CT with EVD in place, decompressed posterior fossa, and resolved hydrocephalus. The cerebellar infarct territories (PICA, AICA, SCA) are illustrated on a schematic diagram with vascular supply labeled. Radiological and anatomical teaching illustration.
</image>

## Clinical Pearls

Decompressive hemicraniectomy has a number needed to treat of 2 for survival in malignant MCA infarction, making it one of the most effective surgical interventions in medicine. The bone flap must be at least 12 cm because an inadequate craniectomy leads to brain herniation through the bone edge, causing venous infarction and worsening outcomes. Surgery should be performed within 48 hours of symptom onset for maximal benefit; waiting for herniation signs to develop before consulting neurosurgery should be avoided. In patients over 60, DHC saves lives but increases survival with severe disability, requiring frank discussion with family about expected outcomes (mRS 4-5 in most elderly survivors). Posterior fossa stroke is a neurosurgical emergency with rapid deterioration from brainstem compression occurring with minimal warning, making early neurosurgical involvement critical. Corticosteroids do not work for cytotoxic edema, which is fundamentally different from tumor-associated vasogenic edema; surgical decompression should not be delayed waiting for steroids to take effect. Cranioplasty timing matters because syndrome of the trephined (neurological decline related to atmospheric pressure on the brain through a large craniectomy defect) may develop weeks after DHC, and cranioplasty can produce dramatic neurological improvement.

## References
- Vahedi K, et al. "Early Decompressive Surgery in Malignant Infarction of the Middle Cerebral Artery: A Pooled Analysis of Three Randomised Controlled Trials." *Lancet Neurol*. 2007;6(3):215-222.
- Juttler E, et al. "Hemicraniectomy in Older Patients with Extensive Middle-Cerebral-Artery Stroke (DESTINY II)." *NEJM*. 2014;370(12):1091-1100.
- Hofmeijer J, et al. "Surgical Decompression for Space-Occupying Cerebral Infarction (HAMLET)." *Lancet Neurol*. 2009;8(4):326-333.
- Wijdicks EF, et al. "Recommendations for the Management of Cerebellar Hemorrhage and Infarction with Hydrocephalus." *Stroke*. 2012;43:e55-e56.
- Powers WJ, et al. "Guidelines for the Early Management of Patients with Acute Ischemic Stroke." *Stroke*. 2019;50(12):e344-e418.